companyprofile
Actions
Al Hammadi Holding
- Main Market
- Health Care Equipment & Svc
Stats Overview
-
Prev. Close 41.95
-
Open 41.95
-
High 42.30
-
Low 41.85
-
No. of Trades 1,301
-
Avg. Trade size* 265
-
Volume Traded 344,622
-
Value Traded (SAR) 14,502,417.85
Performance
- *Average Trade Size = Cumulative / # of Trades
- **52 Week Price Change = (Current Price - Price year ago) / Price year ago x 100
- Historical prices & volume traded data are adjusted to account for all corporate actions.
- MO: Market Order
Trade Updates
Last Trade
Best Bid
Best Offer
52 WEEK
PERFORMANCE
Compare Selected
Select a Maximum of 5 Companies
LoginPortletPopupv2
Actions
AddtoWatchlistv2
Actions
AnnouncmentandCorporateAction
Actions
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
Announcements
Corporate Actions
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
Dividends
| Announced Date | Eligibility Date | Distribution Date | Distribution Way | Dividend Amount |
|---|---|---|---|---|
| 04/08/2024 | 11/08/2024 | 21/08/2024 | Account Transfer | 0.35 |
| 19/05/2024 | 26/05/2024 | 05/06/2024 | Account Transfer | 0.35 |
| 18/03/2024 | 25/03/2024 | 04/04/2024 | Account Transfer | 0.35 |
| 05/11/2023 | 15/11/2023 | 26/11/2023 | Account Transfer | 0.35 |
| 19/06/2023 | 02/07/2023 | 12/07/2023 | Account Transfer | 0.35 |
CompanyProfilev2Financials
Actions
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
Financials
- FINANCIAL INFORMATION
- FINANCIAL STATEMENTS AND REPORTS
- Annually
- Quarterly
| Balance Sheet | 2023-12-31 | |||
|---|---|---|---|---|
| Total Assets |
2,594,448
|
- | - | - |
| Total Liabilities |
749,524
|
- | - | - |
| Total Shareholders Equity (After Deducting the Minority Equity) |
1,844,924
|
- | - | - |
| Total Liabilities and Shareholders Equity |
2,594,448
|
- | - | - |
| Statement of Income | 2023-12-31 | |||
| Total Revenue (Sales/Operating) |
1,176,764
|
- | - | - |
| Net Profit (Loss) before Zakat and Tax |
320,955
|
- | - | - |
| Zakat and Income Tax |
-17,624
|
- | - | - |
| Net Profit (Loss) after Zakat and Tax |
303,331
|
- | - | - |
| Total Comprehensive Income |
302,361
|
- | - | - |
| Profit (Loss) per Share |
1.9
|
- | - | - |
| Cash Flows | 2023-12-31 | |||
| Net Cash From Operating Activities |
350,954
|
- | - | - |
| Net Cash From Investing Activities |
-54,782
|
- | - | - |
| Net Cash From Financing Activities |
-231,537
|
- | - | - |
| Cash and Cash Equivalents, Beginning of the Period |
60,602
|
- | - | - |
| Cash and Cash Equivalents, End of the Period |
125,237
|
- | - | - |
| All Figures in | Thousands | |||
| All Currency In | SAR | |||
| Last Update Date | 2024-03-19 |
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate. The above information does not replace detailed financial statements, as detailed financial statements are the reliable source that must be consulted to obtain accurate financial information.
| Balance Sheet | 2024-06-30 | 2024-03-31 | 2023-09-30 | |
|---|---|---|---|---|
| Total Assets |
2,586,504
|
2,609,351
|
2,586,296
|
|
| Total Liabilities |
671,824
|
756,118
|
747,998
|
|
| Total Shareholders Equity (After Deducting the Minority Equity) |
1,914,680
|
1,853,233
|
1,838,298
|
|
| Total Liabilities and Shareholders Equity |
2,586,504
|
2,609,351
|
2,586,296
|
|
| Statement of Income | 2024-06-30 | 2024-03-31 | 2023-09-30 | |
| Total Revenue (Sales/Operating) |
263,458
|
277,040
|
297,825
|
|
| Net Profit (Loss) before Zakat and Tax |
123,871
|
69,041
|
79,874
|
|
| Zakat and Income Tax |
-6,000
|
-5,000
|
-5,000
|
|
| Net Profit (Loss) after Zakat and Tax |
117,871
|
64,041
|
74,874
|
|
| Total Comprehensive Income |
117,447
|
64,309
|
77,102
|
|
| Profit (Loss) per Share |
0.74
|
0.4
|
0.47
|
|
| Cash Flows | 2024-06-30 | 2024-03-31 | 2023-09-30 | |
| Net Cash From Operating Activities |
248,829
|
142,879
|
342,496
|
|
| Net Cash From Investing Activities |
113,464
|
-5,990
|
-47,095
|
|
| Net Cash From Financing Activities |
-137,495
|
-56,110
|
-170,261
|
|
| Cash and Cash Equivalents, Beginning of the Period |
125,237
|
125,237
|
60,602
|
|
| Cash and Cash Equivalents, End of the Period |
350,035
|
206,016
|
185,743
|
|
| All Figures in | Thousands | Thousands | Thousands | |
| All Currency In | SAR | SAR | SAR | |
| Last Update Date | 2024-08-05 | 2024-05-19 | 2023-11-05 |
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate. The above information does not replace detailed financial statements, as detailed financial statements are the reliable source that must be consulted to obtain accurate financial information.
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
Company Profile
Company overview
The Company shall carry out and implement activities By managing its subsidiaries or participating in the management of other companies in which the Company holds shares and providing the necessary support to them. Investing its funds in equities and other securities in accordance with legal and regulatory controls. Owning real estate and movables necessary to carry out its activity. Providing loans, guarantees and financing for its affiliated companies. Owning the property rights of patents, trademarks, industrial rights, franchises and other intangible rights, and exploiting and leasing them to its subsidiaries or to third parties. Acquiring, developing, investing, selling, buying, renting, leasing, managing, operating and maintaining real estate. The Company shall carry out its activities in accordance with applicable laws, and upon obtaining the required licenses (if any) from competent authorities.
Company History
The Company was established in 1985G in Riyadh as a sole-proprietorship under the name of Al Hammadi Hospital; on 25/01/1425H corresponding to 16/03/2004G Al Hammadi Hospital was converted to a Limited Liability Company under the name of Al Hammadi Hospital Company. Pursuant to the resolution of Al Hammadi Hospital Company shareholders on 13/06/1429H corresponding to 17/06/2008G and in accordance with the ministerial resolution number (316/Q) dated 16/09/1429H corresponding to 16/09/2008G the Company was converted to a Saudi Closed Joint Stock Company under the name of Al Hammadi Company for Development and Investment and the Company was registered in the commercial registry in Riyadh under commercial registration number 1010196714 dated 23/02/1425H corresponding to 13/04/2004G. On 20/07/1435H corresponding to 19/05/2014G the Company obtained the Capital Market Authority approval to increase its capital to be 750 million Saudi Riyals by issuing a new 22.5 million shares through an Initial Public Offering (IPO) within the period from 11/06/2014G to 17/06/2014G. Pursuant the IPO, the Company was listed on Saudi Financial Market (Tadawul) on 17/09/1435H corresponding to 15/07/2014G.
Company Bylaws
Equity Profile
- Authorized Capital (SAR) 1,600,000,000
- Issued Shares 160,000,000
- Paid Capital (SAR) 1,600,000,000
- Par Value/Share 10
- Paid Up Value/Share 10
Last Update :2022-06-22
Investment limits
There are no investment limits on the company shares as per the amended Rules for Qualified Foreign Financial Institutions Investment in Listed Securities and Instructions for the Foreign Strategic Investors Ownership in Listed Companies based on company bylaw and the issued instructions by the related regulators and supervisory authorities.
- Company Details
- BOARD OF DIRECTORS AND SENIOR EXECUTIVES INFORMATION
Investor Relations
Contact Name:
Investor Management
Company Address:
P.O.Box 55004 Riyadh 11534
Contact Details:
Telephone:
0112329999
Fax
: 0112319999
Email
: invest@alhammadi.com
Company Website:
| Name Of Subsidiary | Percentage Of Property | Main Business | Location Of Operation | Country Of Operation |
|---|---|---|---|---|
| Medical Support Services Company | 100.00% | Maintenance, operation and management of hospitals, laboratories and specialized medical centers | Riyadh | kingdom of Saudi Arabia |
| Pharma Serve | 100.00% | Wholesale and retail trade in medical devices and products | Riyadh | kingdom of Saudi Arabia |
| Sudair Pharmaceuticals Company | 35.00% | manufacturing of cancer treatments (oral and intravenous) | Riyadh | kingdom of Saudi Arabia |
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of these disclosures, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of these disclosures, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.